Birin, Aisa .
HRN: 23-95-34 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/11/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
11/11/2023
11/15/2023
IV
2.5g
Q6
T/c Ascending Cholangitis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes